Is a complete MTNB research report available?

No complete published report is available for Matinas BioPharma Holdings, Inc. (MTNB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Matinas BioPharma Holdings, Inc. (MTNB)

NYSEAMERICAN: MTNB · USD

$1.19

+0.05 (+4.4%)· Recorded snapshot

Market cap	1.2M
Net income (ttm)	-7.3M
EPS (ttm)	-$17.9
Shares out	979.5K
Volume	17,071
Beta	2.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7.3M
EPS (ttm): -$17.9
Market cap: 1.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Metric	Value
Amount currency	USD
CIK code	0001582554
Company name	Matinas BioPharma Holdings, Inc.
Country	United States
Country code	US
CUSIP number	576810402
Earnings date	2026-08-13
Earnings time	amc
Employees	2
Employees change	-1
Employees growth	-33.33%
Enterprise value	$410,628
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US5768104029
Last 10-K release date	2026-03-31
Last earnings date	2026-08-13
Last refreshed	2026-11-04
Last stock split date	2026-09-28
Last stock split type	Reverse
Market cap	$1.2M
Market cap category	Nano-Cap
Options	No
Price	$1.19
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-04
Symbol	MTNB
U.S. state	New Jersey
Website	https://www.matinasbiopharma.com

Metric

Value

Amount currency

USD

CIK code

0001582554

Company name

Matinas BioPharma Holdings, Inc.

Country

United States

Country code

CUSIP number

576810402

Earnings date

2026-08-13

Earnings time

amc

Employees

Employees change

-1

Employees growth

-33.33%

Enterprise value

$410,628

Exchange

NYSEAMERICAN

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2013

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US5768104029

Last 10-K release date

2026-03-31

Last earnings date

2026-08-13

Last refreshed

2026-11-04

Last stock split date

2026-09-28

Last stock split type

Reverse

Market cap

$1.2M

Market cap category

Nano-Cap

Options

Price

$1.19

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-11-04

Symbol

MTNB

U.S. state

New Jersey

Website

https://www.matinasbiopharma.com

Metric	Value
Earnings yield	-1,502.02%
FCF / EV yield	-1,775.19%
FCF yield	-574.93%
P/B ratio	0.27x
Price / tangible book value	0.62x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-1,502.02%

FCF / EV yield

-1,775.19%

FCF yield

-574.93%

P/B ratio

0.27x

Price / tangible book value

0.62x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
Profit per employee	$-3.7M
ROA	-56.17%
ROA (5Y)	-41.08%
ROCE	-323.33%
ROE	-141.23%
ROE (5Y)	-103.32%
ROIC	-69.38%

Metric

Value

Profit per employee

$-3.7M

ROA

-56.17%

ROA (5Y)

-41.08%

ROCE

-323.33%

ROE

-141.23%

ROE (5Y)

-103.32%

ROIC

-69.38%

Metric	Value
EPS growth quarters	6
EPS growth years	2
Net income growth quarters	1
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$5,000
EBIT	$-6.7M
EBITDA	$-6.7M
EPS	$-17.87
FCF per share	$-6.55
Financing cash flow	$121,000
Free cash flow	$-6.4M
Free cash flow minus SBC	$-7.1M
Investing cash flow	$335,000
Net borrowing	$-8,000
Net cash flow	$-6M
Net income	$-7.3M
Operating cash flow minus SBC	$-7.1M
Operating income	$-6.7M
Stock-based compensation	$687,000

Metric

Value

Depreciation and amortization

$5,000

EBIT

$-6.7M

EBITDA

$-6.7M

EPS

$-17.87

FCF per share

$-6.55

Financing cash flow

$121,000

Free cash flow

$-6.4M

Free cash flow minus SBC

$-7.1M

Investing cash flow

$335,000

Net borrowing

$-8,000

Net cash flow

$-6M

Net income

$-7.3M

Operating cash flow minus SBC

$-7.1M

Operating income

$-6.7M

Stock-based compensation

$687,000

Metric	Value
Book value per share	$4.21
Debt / equity	0
Interest coverage	-6,667
Long-term assets	$2.3M
Long-term liabilities	$262,000
Net cash (debt)	$755,000
Net cash / market cap	67.61%
Net cash growth	-81.1%
Net debt / equity	-0.42
Piotroski F-Score	1
Property, plant and equipment	$9,000
Shareholders' equity	$1.8M
Tangible book value	$1.8M
Tangible book value per share	$4.21
Total assets	$3.4M
Total cash	$761,000
Total debt	$6,000
Total liabilities	$1.6M
WACC	16.6%

Metric

Value

Book value per share

$4.21

Debt / equity

Interest coverage

-6,667

Long-term assets

$2.3M

Long-term liabilities

$262,000

Net cash (debt)

$755,000

Net cash / market cap

67.61%

Net cash growth

-81.1%

Net debt / equity

-0.42

Piotroski F-Score

Property, plant and equipment

$9,000

Shareholders' equity

$1.8M

Tangible book value

$1.8M

Tangible book value per share

$4.21

Total assets

$3.4M

Total cash

$761,000

Total debt

$6,000

Total liabilities

$1.6M

WACC

16.6%

Metric	Value
Current assets	$1.1M
Current liabilities	$1.4M
Current ratio	0.85
Net working capital	$-967,000
Quick ratio	0.56
Working capital	$-207,000

Metric

Value

Current assets

$1.1M

Current liabilities

$1.4M

Current ratio

0.85

Net working capital

$-967,000

Quick ratio

0.56

Working capital

$-207,000

Metric	Value
Buyback yield / dilution	-20.84%
Dividend yield	0%
Shareholder yield	-20.84%

Metric

Value

Buyback yield / dilution

-20.84%

Dividend yield

Shareholder yield

-20.84%

Metric	Value
10Y price change	-99.9%
10Y return CAGR	-50.02%
10Y total return	-99.9%
150-day SMA	$6.08
1D price change	4.39%
1M price change	-56.06%
1M total return	-56.06%
1W price change	-39.27%
1W total return	-39.27%
1Y price change	-94.23%
1Y return CAGR	-94.24%
1Y total return	-94.23%
20-day SMA	$1.95
200-day SMA	$6.86
3M price change	-74.36%
3M total return	-74.36%
3Y price change	-99.33%
3Y return CAGR	-81.12%
3Y total return	-99.33%
50-day SMA	$2.41
50-day SMA vs 200-day SMA	50under200
52-week high	$20.10
52-week high date	2025-11-04
52-week low	$0.97
52-week low date	2026-11-02
5Y price change	-99.86%
5Y return CAGR	-73.11%
5Y total return	-99.86%
6M price change	-88.94%
6M total return	-88.94%
All-time high	$2,992.50
All-time high date	2017-03-02
All-time low	$0.97
All-time low date	2026-11-02
Average true range (ATR)	$0.29
Average volume	63.2K
Beta (1Y)	1.93
Beta (2Y)	1.7
Beta (5Y)	2.25
Change from 52-week high	-94.08%
Change from 52-week low	23.16%
Change from all-time high	-99.96%
Change from all-time low	20.06%
Change from open	1.71%
Day's gap	2.63%
Dollar volume	$20,314
High price	$1.20
Low price	$1.08
Monthly RSI	32.75
Open price	$1.17
Position in 52-week range	92%
Premarket change	-3.51%
Premarket close	$1.14
Premarket price	$1.10
Premarket volume	208
Previous close	$1.14
Price vs 150-day SMA	-80.91%
Price vs 20-day SMA	-40.36%
Price vs 200-day SMA	-83.09%
Price vs 50-day SMA	-51.89%
Relative volume	0.27
RSI	28.61
Sharpe ratio	-1.67
Sharpe ratio (3Y)	-0.64
Sharpe ratio (5Y)	-0.14
Sortino ratio	-2.07
Sortino ratio (3Y)	-0.84
Sortino ratio (5Y)	-0.24
Volume	17.1K
Weekly RSI	29.2
YTD price change	-86.8%
YTD total return	-86.8%

Metric

Value

10Y price change

-99.9%

10Y return CAGR

-50.02%

10Y total return

-99.9%

150-day SMA

$6.08

1D price change

4.39%

1M price change

-56.06%

1M total return

-56.06%

1W price change

-39.27%

1W total return

-39.27%

1Y price change

-94.23%

1Y return CAGR

-94.24%

1Y total return

-94.23%

20-day SMA

$1.95

200-day SMA

$6.86

3M price change

-74.36%

3M total return

-74.36%

3Y price change

-99.33%

3Y return CAGR

-81.12%

3Y total return

-99.33%

50-day SMA

$2.41

50-day SMA vs 200-day SMA

50under200

52-week high

$20.10

52-week high date

2025-11-04

52-week low

$0.97

52-week low date

2026-11-02

5Y price change

-99.86%

5Y return CAGR

-73.11%

5Y total return

-99.86%

6M price change

-88.94%

6M total return

-88.94%

All-time high

$2,992.50

All-time high date

2017-03-02

All-time low

$0.97

All-time low date

2026-11-02

Average true range (ATR)

$0.29

Average volume

63.2K

Beta (1Y)

1.93

Beta (2Y)

1.7

Beta (5Y)

2.25

Change from 52-week high

-94.08%

Change from 52-week low

23.16%

Change from all-time high

-99.96%

Change from all-time low

20.06%

Change from open

1.71%

Day's gap

2.63%

Dollar volume

$20,314

High price

$1.20

Low price

$1.08

Monthly RSI

32.75

Open price

$1.17

Position in 52-week range

92%

Premarket change

-3.51%

Premarket close

$1.14

Premarket price

$1.10

Premarket volume

208

Previous close

$1.14

Price vs 150-day SMA

-80.91%

Price vs 20-day SMA

-40.36%

Price vs 200-day SMA

-83.09%

Price vs 50-day SMA

-51.89%

Relative volume

0.27

RSI

28.61

Sharpe ratio

-1.67

Sharpe ratio (3Y)

-0.64

Sharpe ratio (5Y)

-0.14

Sortino ratio

-2.07

Sortino ratio (3Y)

-0.84

Sortino ratio (5Y)

-0.24

Volume

17.1K

Weekly RSI

29.2

YTD price change

-86.8%

YTD total return

-86.8%

Metric	Value
Float	763.1K
Float percentage	77.9%
Shares change (QoQ)	0%
Shares change (YoY)	20.84%
Shares held by insiders	11.96%
Shares held by institutions	2.58%
Shares outstanding	979.5K
Short % of float	6.48%
Short % of shares	5.05%
Short ratio	0.4 days

Metric

Value

Float

763.1K

Float percentage

77.9%

Shares change (QoQ)

Shares change (YoY)

20.84%

Shares held by insiders

11.96%

Shares held by institutions

2.58%

Shares outstanding

979.5K

Short % of float

6.48%

Short % of shares

5.05%

Short ratio

0.4 days

Matinas BioPharma Holdings, Inc. (MTNB)

Price

Financial snapshot

Fair-value bridge

Latest news · MTNB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MTNB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MTNB

Frequently asked questions